About MVS Pharma - MVS Pharma

Home » About MVS Pharma

Our mission is to bridge healthcare gaps by providing innovative, quality-assured products that meet the needs of a rapidly evolving health landscape.

MVS Pharma GmbH is an innovative start-up and wholesaler located in Stuttgart, Germany. The Founder & CEO of MVS Pharma GmbH is Rainer Proksch. The company has its own international team of professionals and experts in many fields, such as natural biology, chemistry, molecular genetics, biotechnology, medical engineering, and pharmacy.

The main goal of the company is the well-being and safety of its customers, which is why all products are created using only the best raw materials, free from heavy metals, pesticides, plastic, etc.

MVS Pharma is currently working on several big projects, including the development and test of Virudol® Antivirual Mouth and Nasal Spray, the manufacturing and merchandising of high-quality, all-natural supplements, such as MVS Omega-3, with revolutionary packaging, aiming to reduce oxidation and fat-burning product coming straight from nature – LipoShin.

In response to Germany’s ongoing medicine shortage crisis, MVS Pharma has stepped up to address critical supply challenges. By actively facilitating the importation of essential medications, we’re dedicated to ensuring that healthcare providers and patients have reliable access to life-saving treatments.

Through our Indian office, we have established direct contacts with key suppliers of medicine and raw materials for the manufacture of supplements in India.

Our Story

MVS Pharma GmbH has been developed out of the founder's passion to help people stay healthy and protect against the most common cold viruses, such as Rhino Virus, Influenza Virus and Corona Virus. Since the emergence of the Covid-19 virus, back in 2019, millions of people got infected with the extremely dangerous virus. Pharmaceutical companies worldwide were focused on the production of vaccines. Vaccination protection and the risk of infection are two very different areas after all. Therefore, people also try to protect themselves by wearing masks and using PCR and rapid tests. The founder of MVS Pharma GmbH, Rainer Proksch, wondered if there is another way to reduce viral load and making mask-wearing optional.

Breaking grounds in innovation

Until this moment no company has dealt intensively with the question of “whether a solution could not be found” in which all people would be protected against transmission of viruses for a period of several hours, only by administrating natural substances.

This is when an idea came to Mr. Proksch and he commissioned a study to find out if there are natural substances, which in the perfect combination, would grant a higher and longer-lasting protection against viral transmission. The result after various and extensive trials and tests is Virudol®.

The ground breaking product is unique not only because of its all natural substance ingredients, but also because the spray bottle is so innovativly designed that spraying into the mouth and nose is only a matter of finest nebulization and there are no droplets or a jet, which could be very uncomfortable.

Furthermore…

In addition, the requirement for the creation of the bottle was not to use any preservatives in order not to limit the naturalness and possibly multiple uses. Durability and protection against heat should also be guaranteed.

All in all, these factors give people intensive protection against the transmission of above-mentioned viruses for the duration of several hours in a completely natural and pleasant way.

Additionally, Virudol ®’s protection system has a further task, which is an air system (ventilation component) that distributes the well-smelling natural substances that bind to transmissible airborne viruses. So the load of infectious viruses in areas where many people come together is reduced. The technology for the antiviral system Virudol® uses a novel combination of natural plant based and algae substances in a defined specific way to protect people, reduce viral load and provide prophylaxis.

The outcome of using Virudol air system will be to reduce the load of infections in areas where many people come together.

Virudol® has so far been completely self-financed, for which a patent has also been registered.

Virudol® is a registered trademark in the EU and has also been registered in Qatar.

*No one, including us, can guarantee 100% protection against viruses, but the use of Virudol® can be a first step in this direction.

Join the insiders

Be the first to find out about our products' development updates, time-frame releases, and future promotion and discounts. (No spamming, you will only get quality free content and your information will be secured).